Laparoscopic vagal nerve blocking device explantation: case series and report of operative technique

Tarin C. Worrest, Bruce Wolfe, Samer Mattar, Erin Gilbert

Research output: Contribution to journalArticle

Abstract

Background: Vagal nerve blockade with the vBloc device (ReShape Lifesciences, St. Paul, MN) has been shown to provide durable 2-year weight loss in patients with moderate obesity. These devices may require removal. We present a series of patients and report our technique for laparoscopic removal of this device. Methods: From December 2009 to December 2016, the medical records of patients who underwent laparoscopic explantation of a vagal blocking device at our institution were retrospectively reviewed. All patients initially underwent device placement as part of a multi-center, randomized, controlled trial. The device leads were removed with the application of firm traction in order to safely dissect them away from the stomach and esophagus as the body tended to form a fibrotic capsule surrounding the leads. Operative details, length of stay, 30-day post-operative complications, demographics and reasons for device removal were reported. Results: Thirty patients were identified. Median age was 54 (37–65) years. Average operative time was 227.63 (± 100.21) min. Median time from implantation to removal was 41 (11–96) months. Removal reasons included device malfunction (7 patients, 23.3%), pain at the neuroregulator site (5 patients, 16.7%), retrosternal or epigastric pain (11 patients, 36.7%), weight regain or dissatisfaction with weight loss (15 patients, 50%), and severe nausea (2 patients, 6.7%). Two patients (6.7%) had Clavien–Dindo grade II complications following explantation. Thirteen patients (43.3%) had dense adhesions noted at the time of operation. Seroma formation at the neuroregulator site was the most common complication (7 patients, 23.3%). Conclusion: The vagal nerve blocking device can be safely removed laparoscopically with a low 30-day complication rate. Surgeons should be familiar with the details of the device appearance, the typical lead location, and should anticipate dense adhesions surrounding the leads. In addition, experience operating in the region of the gastroesophageal junction is imperative.

Original languageEnglish (US)
JournalSurgical Endoscopy
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Equipment and Supplies
Device Removal
Neurotransmitter Agents
Weight Loss
Seroma
Esophagogastric Junction
Nerve Block
Traction
Operative Time
Nausea
Esophagus
Capsules
Medical Records
Length of Stay
Stomach
Randomized Controlled Trials
Obesity
Demography
Weights and Measures

Keywords

  • Bariatric surgery
  • Vagal blocking device
  • vBloc

ASJC Scopus subject areas

  • Surgery

Cite this

Laparoscopic vagal nerve blocking device explantation : case series and report of operative technique. / Worrest, Tarin C.; Wolfe, Bruce; Mattar, Samer; Gilbert, Erin.

In: Surgical Endoscopy, 01.01.2019.

Research output: Contribution to journalArticle

@article{4487e31e6a8b436393ddce3880363774,
title = "Laparoscopic vagal nerve blocking device explantation: case series and report of operative technique",
abstract = "Background: Vagal nerve blockade with the vBloc device (ReShape Lifesciences, St. Paul, MN) has been shown to provide durable 2-year weight loss in patients with moderate obesity. These devices may require removal. We present a series of patients and report our technique for laparoscopic removal of this device. Methods: From December 2009 to December 2016, the medical records of patients who underwent laparoscopic explantation of a vagal blocking device at our institution were retrospectively reviewed. All patients initially underwent device placement as part of a multi-center, randomized, controlled trial. The device leads were removed with the application of firm traction in order to safely dissect them away from the stomach and esophagus as the body tended to form a fibrotic capsule surrounding the leads. Operative details, length of stay, 30-day post-operative complications, demographics and reasons for device removal were reported. Results: Thirty patients were identified. Median age was 54 (37–65) years. Average operative time was 227.63 (± 100.21) min. Median time from implantation to removal was 41 (11–96) months. Removal reasons included device malfunction (7 patients, 23.3{\%}), pain at the neuroregulator site (5 patients, 16.7{\%}), retrosternal or epigastric pain (11 patients, 36.7{\%}), weight regain or dissatisfaction with weight loss (15 patients, 50{\%}), and severe nausea (2 patients, 6.7{\%}). Two patients (6.7{\%}) had Clavien–Dindo grade II complications following explantation. Thirteen patients (43.3{\%}) had dense adhesions noted at the time of operation. Seroma formation at the neuroregulator site was the most common complication (7 patients, 23.3{\%}). Conclusion: The vagal nerve blocking device can be safely removed laparoscopically with a low 30-day complication rate. Surgeons should be familiar with the details of the device appearance, the typical lead location, and should anticipate dense adhesions surrounding the leads. In addition, experience operating in the region of the gastroesophageal junction is imperative.",
keywords = "Bariatric surgery, Vagal blocking device, vBloc",
author = "Worrest, {Tarin C.} and Bruce Wolfe and Samer Mattar and Erin Gilbert",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00464-018-06643-4",
language = "English (US)",
journal = "Surgical Endoscopy and Other Interventional Techniques",
issn = "0930-2794",
publisher = "Springer New York",

}

TY - JOUR

T1 - Laparoscopic vagal nerve blocking device explantation

T2 - case series and report of operative technique

AU - Worrest, Tarin C.

AU - Wolfe, Bruce

AU - Mattar, Samer

AU - Gilbert, Erin

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Vagal nerve blockade with the vBloc device (ReShape Lifesciences, St. Paul, MN) has been shown to provide durable 2-year weight loss in patients with moderate obesity. These devices may require removal. We present a series of patients and report our technique for laparoscopic removal of this device. Methods: From December 2009 to December 2016, the medical records of patients who underwent laparoscopic explantation of a vagal blocking device at our institution were retrospectively reviewed. All patients initially underwent device placement as part of a multi-center, randomized, controlled trial. The device leads were removed with the application of firm traction in order to safely dissect them away from the stomach and esophagus as the body tended to form a fibrotic capsule surrounding the leads. Operative details, length of stay, 30-day post-operative complications, demographics and reasons for device removal were reported. Results: Thirty patients were identified. Median age was 54 (37–65) years. Average operative time was 227.63 (± 100.21) min. Median time from implantation to removal was 41 (11–96) months. Removal reasons included device malfunction (7 patients, 23.3%), pain at the neuroregulator site (5 patients, 16.7%), retrosternal or epigastric pain (11 patients, 36.7%), weight regain or dissatisfaction with weight loss (15 patients, 50%), and severe nausea (2 patients, 6.7%). Two patients (6.7%) had Clavien–Dindo grade II complications following explantation. Thirteen patients (43.3%) had dense adhesions noted at the time of operation. Seroma formation at the neuroregulator site was the most common complication (7 patients, 23.3%). Conclusion: The vagal nerve blocking device can be safely removed laparoscopically with a low 30-day complication rate. Surgeons should be familiar with the details of the device appearance, the typical lead location, and should anticipate dense adhesions surrounding the leads. In addition, experience operating in the region of the gastroesophageal junction is imperative.

AB - Background: Vagal nerve blockade with the vBloc device (ReShape Lifesciences, St. Paul, MN) has been shown to provide durable 2-year weight loss in patients with moderate obesity. These devices may require removal. We present a series of patients and report our technique for laparoscopic removal of this device. Methods: From December 2009 to December 2016, the medical records of patients who underwent laparoscopic explantation of a vagal blocking device at our institution were retrospectively reviewed. All patients initially underwent device placement as part of a multi-center, randomized, controlled trial. The device leads were removed with the application of firm traction in order to safely dissect them away from the stomach and esophagus as the body tended to form a fibrotic capsule surrounding the leads. Operative details, length of stay, 30-day post-operative complications, demographics and reasons for device removal were reported. Results: Thirty patients were identified. Median age was 54 (37–65) years. Average operative time was 227.63 (± 100.21) min. Median time from implantation to removal was 41 (11–96) months. Removal reasons included device malfunction (7 patients, 23.3%), pain at the neuroregulator site (5 patients, 16.7%), retrosternal or epigastric pain (11 patients, 36.7%), weight regain or dissatisfaction with weight loss (15 patients, 50%), and severe nausea (2 patients, 6.7%). Two patients (6.7%) had Clavien–Dindo grade II complications following explantation. Thirteen patients (43.3%) had dense adhesions noted at the time of operation. Seroma formation at the neuroregulator site was the most common complication (7 patients, 23.3%). Conclusion: The vagal nerve blocking device can be safely removed laparoscopically with a low 30-day complication rate. Surgeons should be familiar with the details of the device appearance, the typical lead location, and should anticipate dense adhesions surrounding the leads. In addition, experience operating in the region of the gastroesophageal junction is imperative.

KW - Bariatric surgery

KW - Vagal blocking device

KW - vBloc

UR - http://www.scopus.com/inward/record.url?scp=85059870893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059870893&partnerID=8YFLogxK

U2 - 10.1007/s00464-018-06643-4

DO - 10.1007/s00464-018-06643-4

M3 - Article

AN - SCOPUS:85059870893

JO - Surgical Endoscopy and Other Interventional Techniques

JF - Surgical Endoscopy and Other Interventional Techniques

SN - 0930-2794

ER -